Blood pressure readings taken in a physician's office can vary due to timing, equipment, and biological factors. Studies have linked variability between visits to an increased risk of cardiovascular disease and death, but little was known about its real-world implications. A retrospective cohort study of over 500,000 adults with more than 7.7 million blood pressure measurements found that visit-to-visit variability in blood pressure was associated with an increased risk of cardiovascular events and all-cause mortality. The study's findings suggest that blood pressure management needs to be reassessed to better account for visit-to-visit variability in real-world practice.

The Food and Drug Administration (FDA) in the US is in charge of ensuring the security of implantable medical devices. There are about thousands of different kinds of devices available, ranging from pacemakers to artificial joints, to brain implants. Many are secure and safe as regulated by the FDA, however, the medical system is not perfect and is a very large business. There are risks associated with all medical device implants, even the most routine ones.

The House Energy and Commerce Committee today voted 53-2 in favor of reporting the American Data Privacy and Protection Act as amended.